Pharma trademarks in Brazil: going to court to get your name

21-02-2018

Isabella Cardozo, Robert Daniel-Shores and Rafael Rocha

Pharma trademarks in Brazil: going to court to get your name

Cecilie_Arcurs / iStockphoto.com

Drug makers should consider taking court action to register their brand names if these have been rejected by Brazil’s IP office, as Isabella Cardozo, Robert Daniel-Shores and Rafael Rocha of Daniel Legal & IP Strategy explain.


Isabella Cardozo, Robert Daniel-Shores, Rafael Rocha, Daniel Legal & IP Strategy, trademark, Brazilian Patent and Trademark Office, INPI, ANVISA

WIPR